15^th International Conference on Pharmaceutical Formulations & Drug Delivery September 17-18, 2018 Philadelphia, USA

Dimiter Avtanski is Director, Endocrine Research Laboratory at Lenox Hill Hospital, Assistant Professof of Medicine at Hofstra Northwell School of Medicine at Hofstra University

Strategies to overcome leptin signaling in breast cancer Direct effects of estrogens on somatotroph function

Dr Larhrib was educated at the University of Sciences and Technology, Lille I and the faculty of Pharmacy, Lille II, France where he obtained an MSc Biochem, DU Pharm, DESS Pharm. Tech., a certificate in Pharm. Chemistry and . He moved to the UK to do a PhD in Pharmaceutical technology at Liverpool John Moores University, using high speed compaction simulator to fundamentally study the mechanism of compaction of pharmaceutical powders under the supervision of Dr. James Wells and Prof. Mike Rubinstein (1994-1998). Following his PhD, Dr Larhrib worked for 4 years (1998-2002) as Senior Research Fellow in Pharmaceutics at the Department of Pharmacy, King’s College London. He worked at Liverpool John Moores University as a Senior lecturer in Pharmaceutics for 6 years (2002-2007) before joining the industry; Solid Solution Limited, Liverpool (2007-2010). He was involved in cosmetic products development and manufacture. He moved to Medway school of Pharmacy before joining the University of Huddersfield as a Senior lecturer in Pharmaceutics in July 2011. Dr. Larhrib is a regular reviewer for many international Pharmaceutical journals and member of editorial board of journal of International Research in Medical and Pharmaceutical Sciences and British Journal of Pharmaceutical Research. He is an academic member of Royal Pharmaceutical Society of Great Britain and Fellow of HEA.

Research interests: - Mechanism of compaction of Pharmaceutical powders. - Particle Engineering to enhance therapeutic value of medicines. - Nanomedicine design, formulation and delivery. - Transdermal drug delivery - Pharmaceutical Aerosols - Cosmetics design, formulation and manufacture.

Esmaiel Jabbari is a tenured Full Professor of Chemical and Biomedical Engineering and the Director of Biomaterials, Tissue Engineering and Drug Delivery at University of South Carolina. He earned his Ph.D. from Purdue University in Chemical Engineering and began his independent career as an Assistant Professor in the Departments of Biomedical Engineering and Orthopedic Research at Mayo Clinic upon completion of his post-doctoral training at Monsanto and Rice University. Prof. Jabbari specializes in the development of 3D tissue models for skeletal tissue regeneration and tissue models for drug delivery to cancer stem cells. Prof. Jabbari has received numerous awards for his research including the Berton Rahn Award in 2012 from the AO Foundation, the Stephen Milam Award in 2008 from the Oral and Maxillofacial Surgery Foundation, and election to the College of Fellows of AIMBE in 2013. He is the author of >260 refereed articles and he has mentored >130 scholars. He serves as the Academic Editor for PLOS ONE, Associate Editor for Gels, and the Programming Chair for the Bionanotechnology theme of Engineering in Medicine & Biology Society (EMBS).

Bioinspired materials, Skeletal tissue engineering, Multi‐scale composite materials, Self-assembled nanogels for growth factor delivery, Drug targeting to cancer stem cells, Stem cell encapsulation and delivery, Three-dimensional tissue models

Dr. Dimitris Drikakis is Professor of Engineering Science and Executive Dean (Engineering) and Associate Principal and at the University of Strathclyde, Glasgow (till June 2017). Since July 2017, and in addition to his continued Professorial role, Dimitris has taken on new leadership roles as Executive Director of Global University Partnerships (US and Far East), Executive Director of the Strathclyde Space Institute. Prior to his current appointment, he was Head of Aerospace Sciences at Cranfield University and Professor of Fluid Mechanics & Computational Science (2003-2015); Professor of Fluid Mechanics at Queen Mary University of London (till 2003); and has also held academic positions at the University of Manchester; University of Erlangen-Nuremberg, Germany; and University of Marseille, France. His expertise is in computational fluid dynamics (CFD), fluid mechanics (particularly compressible flows), and micro/nanoscale processes at fluid-solid interfaces. He has been active in both fundamental and applied research across Engineering and Applied Physics, including Aerospace, Mechanical, Nuclear (Defence and Fusion), and Oil and Gas Applications. His work has directly influenced areas as diverse as improved understanding of complex aerodynamic and gas dynamic flows, turbulent mixing in inertial confinement fusion, and novel gas filtration nanotechnologies using carbon nanotubes. He has received: 1) The William Penney Fellowship Award (twice in 2008 and 2011) by the Atomic Weapons Establishment (AWE Plc) in recognition of his contributions to compressible fluid dynamics. 2) The Innovator of the Year Award (2014) by the Innovation Institute for a new generation carbon capture technology that uses carbon nanotubes for filtering out carbon dioxide and other gases at low or zero energy cost. This platform technology has the potential to be used across a wide range of applications in the power generation, automotive, aerospace, chemical, marine and built environment sectors. 3) The Technical Achievement Award at the International Conference on Mathematical Problems in Engineering, Aerospace and Sciences. To date, he has co-authored two books in the field of computational fluid dynamics and has published 161 journal and 238 conference papers/book chapters in the above technical areas. He has graduated 52 PhD students who now hold positions in academia and industries around the world. He has served on the Fluid Dynamics Technical Committee of the American Institute of Aeronautics and Astronautics (AIAA); is a member of the Board of Directors of the European Aeronautics Science Network (EASN); an expert evaluator for the European Commission and the European Research Council (ERC); and on the Advisory Board of Japan-Europe Aerospace Research and Technology Co-operation. He has been an associate editor of the ASME Journal of Fluids Engineering; The Aeronautical Journal of the Royal Aeronautical Society; and the Journal of Computational and Theoretical Nanoscience

Fluid Dynamics,Engineering and Applied Physics,Aerospace, Mechanical, Nuclear (Defence and Fusion), and Oil and Gas Applications

Nigel Langley, Director Technical Service and Scientific Affairs – BASF Pharma Solutions, provides technical support to the pharmaceutical industry and helps solve drug development challenges with BASF's platform solutions. Prior to joining BASF, Dr. Langley worked for Croda Inc. as Technical Director Health Care, responsible for product and application development for both dietary supplements and Pharmaceutical excipients. He has also worked in Japan and England with Croda. He gained his Chemistry (Hons) degree and PhD (Liquid Crystals) from the University of Hull, (UK) and an MBA from Leeds University (UK). Nigel has been a member of the Executive Committee at IPEC Americas since 2010 and is currently VC Makers and Users. He is also helping to lead the Novel excipient initiative in collaboration with the IQ Pharma Consortium. Nigel is also active in the BioPhorum Operations Group (BPOG) and has 30 years’ experience within the Pharmaceutical excipient industry

Formulations, novel excipients